Skip to main content
SpringerLink
Log in

Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Amino acid restriction modulates tumor growth, although effects on metastasis are poorly documented. We demonstrate that low levels of tyrosine (Tyr) and phenylalanine (Phe) suppress metastasis of B16-BL6 melanoma and that these effects are specific to these two amino acids. Weight loss and sustained low body weight in mice fed low Tyr and Phe diet do not contribute to the antimetastatic effects. Furthermore, methionine (Met) restriction, which decreased survival of mice inoculated i.p. with B16 melanoma, only slightly inhibited spontaneous metastasis compared to the dramatic inhibition during Tyr and Phe restriction. Tyr and Phe restriction inhibited spontaneous metastasis by impairing the ability of tumor cells to establish metastatic foci and not via differential tumor cell removal from the blood. Spontaneous metastasis is blocked by Tyr and Phe intervention even in mice with established lymph node tumors. Tumors isolated from mice fed low Tyr and Phe diet reinoculated into mice fed normal diet exhibited lower experimental metastatic potential, reflected by decreased formation of lung tumor colonies and increased survival of inoculated mice. This decrease in metastatic potential is not associated with tumor chemosensitivity. These findings indicate that Tyr and Phe restriction could become an important adjuvant to effective melanoma treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abell, C. W., Hodgins, D. S., and Stith, W. J., 1973, An in vivo evaluation of the chemotherapeutic potency of phenylalanine ammonia-lyase. Cancer Research, 33, 2529–2532.

    Google Scholar 

  2. [2]Abdallah, R. M., Starkey, J. R., and Meadows, G. G., 1987, Dietary restriction of tyrosine and phenylalanine: Inhibition of metastasis of three rodent tumors. Journal of the National Cancer Institute, 78, 759–769.

    Google Scholar 

  3. Abdallah, R. M., Starkey, J. R., and Meadows, G. G., 1983, Alcohol and related dietary effects on mouse natural killer-cell activity. Immunology, 50, 131–137.

    Google Scholar 

  4. Abou-El-Ela, S. H., Prasse, K. W., Farrell, R. L., Carroll, R. W. Wade, A. E., and Bunce, O. R., 1989, Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Research, 49, 1434–1440.

    Google Scholar 

  5. Allison, D. C., Bose, K. K., Anderson, S., Curley, S., and Robertson, J., 1989, Slowing of cell cycle traverse for cells in exponential monolayer cultures placed into plateau-fed and starved medium. Cancer Research, 49, 1456–1464.

    Google Scholar 

  6. Asselin, B. L., Ryan, D., Frantz, C. N., Bernal, S. D., Leavitt, P., Sallan, S. E., and Cohen, H. J., 1989, In vitro and in vivo killing of acute lymphoblastic leukemia cells by l-asparaginase. Cancer Research, 49, 4363–4368.

    Google Scholar 

  7. Girt, D. F., White, L. T., Choi, B., and Pelling, J. C., 1989, Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse. Cancer Research, 49, 4170–4174.

    Google Scholar 

  8. Bounous, G., and Kongshavn, P. A. L., 1978, The effect of dietary amino acids on immune reactivity. Immunology, 35, 257–266.

    Google Scholar 

  9. Bounous, G., Sadarangani, C., Pang, K. C., and Kongshavn, P. A. L., 1981, Effect of dietary amino acids on tumor growth and cell mediated immune responses. Clinical Investigations in Medicine, 4, 109–115.

    Google Scholar 

  10. Boylan, E. S., and Cohen, L. A., 1986, The influence of dietary fat on mammary tumor metastasis in the rat. Nutrition and Cancer, 8, 193–200.

    Google Scholar 

  11. Branda, R. F., McCormack, J. J., Perlmutter, C. A., Mathews, L. A., and Robison, S. H., 1988, Effects of folate deficiency on the metastatic potential of murine melanoma cells. Cancer Research, 48, 4529–4534.

    Google Scholar 

  12. Breillout, F., Poupon, M. F., Blanchard, P., Lascaux, V., Echinard-Garin, P., and Robert-Gero, M., 1988, Association of SIBA treatment and a Met-depleted diet inhibits in vitro growth and in vivo metastatic spread of experimental tumor cell lines. Clinical and Experimental Metastasis, 6, 3–16.

    Google Scholar 

  13. Brown, J. M., and Parker, E. T., 1979, Host treatments affecting artificial pulmonary metastases: interpretation of loss of radioactivity labelled cells from lungs. British Journal of Cancer, 40, 677–688.

    Google Scholar 

  14. Cillo, C., Dick, J. E., Ling, V., and Hill, R. P., 1987, Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines. Cancer Research, 47, 2604–2608.

    Google Scholar 

  15. Conley, F. K., 1982, Effect of immunomodulation of the fate of tumor cells in the central nervous system and systemic organs of mice. Distribution of [125I]5-iodo-2′-deoxyuridine-labeled KHT tumor cells after left intracardial injection. Journal of the National Cancer Institute, 69, 465–473.

    Google Scholar 

  16. Demetrakopoulos, G. Ev., and Brennan, M. F., 1982, Tumoricidal potential of nutritional manipulations. Cancer Research, 42, 756s–765s.

  17. Demopoulos, H. B., 1966, Effects of low phenylalanine-tyrosine diets on S91 mouse melanomas. Journal of the National Cancer Institute, 37, 185–190.

    Google Scholar 

  18. Elmer, G. W., Linden, C., and Meadows, G. G., 1979, Influence of l-tyrosine phenollyase on the growth and metabolism of B16 melanoma. Cancer Treatment Reports, 63, 1055–1062.

    Google Scholar 

  19. Elmer, G. W., Meadows, G. G., Linden, C., Digiovanni, J., and Holcenberg, J., 1976, Influence of tyrosine phenol-lyase and phenylalanine ammonia-lyase on growth of B-16 melanoma. Pigment Cell, Vol. 2, edited by V. Riley (Basel: S. Karger AG), pp. 339–346.

    Google Scholar 

  20. Ershler, W. B., Berman, E., and Moore, A. L., 1986, Slower B16 melanoma growth but greater pulmonary colonization in calorie-restricted mice. Journal of the National Cancer Institute, 76, 81–85.

    Google Scholar 

  21. Fidler, I. J., 1970, Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2′-deoxyuridine. Journal of the National Cancer Institute, 45, 773–782.

    Google Scholar 

  22. Gardiner, N. S., and Duncan, J. R., 1989, Inhibition of murine melanoma growth by sodium ascorbate. Journal of Nutrition, 119, 586–590.

    Google Scholar 

  23. Goldie, J. H., and Coldman, A. J., 1979, A mathematical model for relating the drug sensitivity of tumors to the spontaneous mutation rate. Cancer Treatment Reports, 63, 1727–1733.

    Google Scholar 

  24. Hart, I. R., 1979, The selection and characterization of an invasive variant of the B16 melanoma. American Journal of Pathology, 97, 587–600.

    Google Scholar 

  25. Hart, I. R., and Fidler, I. J., 1981, The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochimica et Biophysica Acta, 651, 37–50.

    Google Scholar 

  26. Heppner, G. H., and Miller, B. E., 1983, Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Review, 2, 5–23.

    Google Scholar 

  27. Hoffman, R. M., 1982, Methionine dependence in cancer cells—A review. In vitro, 18, 421–428.

    Google Scholar 

  28. Hoffman, R. M., 1985, Altered methionine metabolism and transmethylation in cancer. Anticancer Research, 5, 1–30.

    Google Scholar 

  29. Jones, R. C., Sugie, S., Braley, J., and Weisburger, J. H., 1989, Dietary β-carotene in rat models of gastrointestinal cancer. Journal of Nutrition, 119, 508–514.

    Google Scholar 

  30. Jose, D. G., and Good, R. A., 1973, Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice. Journal of Experimental Medicine, 137, 1–9.

    Google Scholar 

  31. Juacaba, S. F., Horak, E., Price, J. E., and Tarin, D., 1989, Tumor cell dissemination patterns and metastasis of murine mammary carcinoma. Cancer Research, 49, 570–575.

    Google Scholar 

  32. Judde, J. G., Ellis, M., and Frost, P., 1989, Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Research, 49, 4859–4865.

    Google Scholar 

  33. Katz, E. B., and Boylan, E. S., 1989, Effects of reciprocal changes of diets differing in fat content on pulmonary metastasis from the 13762 rat mammary tumor. Cancer Research, 49, 2477–2484.

    Google Scholar 

  34. Legha, S. S., 1989, Current therapy for malignant melanoma. Seminars in Oncology, 16, 33–44.

    Google Scholar 

  35. Liteplo, R. G., 1989, Altered methionine metabolism in metastatic variants of a human melanoma cell line. Cancer Letters, 44, 23–31.

    Google Scholar 

  36. Lorincz, A. B., Kuttner, R. B., and Brandt, M. B., 1969, Tumor response to phenylalanine-tyrosine limited diets. Journal of the American Dietetic Association, 54, 198–205.

    Google Scholar 

  37. Meadows, G. G., Abdallah, R. M., and Starkey, J. R., 1986, Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma. Cancer Chemotherapy and Pharmacology, 16, 229–236.

    Google Scholar 

  38. Meadows, G. G., Abdallah, R. M., Starkey, J. R., and Aslakson, C. J., 1988, Response of natural killer cells from dietary tyrosine and phenylalanine restricted mice to biological response modifiers. Cancer Immunology and Immunotherapy, 26, 67–73.

    Google Scholar 

  39. Meadows, G. G., Digiovanni, J., Minor, L., and Elmer, G. W., 1976, Some biological properties and an in vivo evaluation of tyrosine phenol-lyase on the growth of B16 melanoma. Cancer Research, 36, 167–171.

    Google Scholar 

  40. Meadows, G. G., and Oeser, D. E., 1983, Response of B16 melanoma-bearing mice to varying levels of phenylalanine and tyrosine. Nutrition Reports International, 28, 1073–1082.

    Google Scholar 

  41. Meadows, G. G., Pierson, H. F., Abdallah, R. M., and Desai, P. R., 1982, Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopalevodopa methyl ester chemotherapy. Cancer Research, 42, 3056–3063.

    Google Scholar 

  42. Medina, D., and Oborn, C. J., 1981, Differential effects of selenium on the growth of mouse mammary cells in vitro. Cancer Letters, 13, 333–344.

    Google Scholar 

  43. Miller, T. J., Franco, R. S., Chance, W. T., Martelo, J., and Popp, M. B., 1987, Amino acid requirements of a rat sarcoma as determined by a stem cell assay. Journal of Parenteral and Enteral Nutrition, 11, 223–228.

    Google Scholar 

  44. Noto, V., Taper, H. S., Yi-hua, J., Janssens, J., Bonte, J., and Deloecker, W., 1989, Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. Cancer, 63, 901–906.

    Google Scholar 

  45. Nowell, P. C., 1976, The clonal evolution of tumor cell populations. Science, 194, 23–28.

    Google Scholar 

  46. Patterson, M. K., 1972, Uptake and utilization of amino acids by cell cultures. Growth, Nutrition, and Metabolism of Cells in Culture, edited by G. H. Rothblast and V. J. Cristofalo (New York: Academic Press), pp. 171–209.

    Google Scholar 

  47. Pezzuto, J. M., Shieh, H.-L., Shaughnessy, E., and Beattie, C. W., 1988, Approaches for drug development in treatment of advanced melanoma. Seminars in Oncology, 15, 578–588.

    Google Scholar 

  48. Pierson, H. F., and Meadows, G. G., 1983, Sodium ascorbate enhancement of carbidopa-methyl ester antitumor activity against pigmented B16 melanoma. Cancer Research, 43, 2047–2051.

    Google Scholar 

  49. Pierson, H. F., and Meadows, G. G., 1985, Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation. Journal of the National Cancer Institute, 75, 507–516.

    Google Scholar 

  50. Pine, M. J., 1978, Effect of low phenylalanine diet on murine leukemia Ll210. Journal of the National Cancer Institute, 60, 633–641.

    Google Scholar 

  51. Pine, M. J., 1981, Improved host defense against L1210 leukemia by deprivation of dietary phenylalanine. Nutrition and Cancer, 3, 94–102.

    Google Scholar 

  52. Price, J. E., and Tarin, D., 1982, Retention of ‘metastatic’ colonisation potential by cells of spontaneous primary tumors after cryopreservation. British Journal of Cancer, 45, 790–793.

    Google Scholar 

  53. Reinhold, U., Biltz, H., Bayer, W., and Schmidt, K. H., 1989, Serum selenium levels in patients with malignant melanoma. Acta Dermatovenereologica (Stockholm), 69, 132–136.

    Google Scholar 

  54. Rogers, A. E., Nields, H. M., and Newberne, P. M., 1987, Nutritional and dietary influences on liver tumorigenesis in mice and rats. Archives of Toxicology (Suppl. 10), 231–243.

  55. Ross, D. W., and Capizzi, R. L., 1984, Differentiation versus cytoreduction during remission induction in acute nonlymphoblastic leukemia treated with sequential highdose ara-C and asparaginase. Cancer, 53, 1651–1654.

    Google Scholar 

  56. Ruggeri, B. A., Klurfeld, D. M., Kritchevsky, D., and Furlanetto, R. W., 1989, Growth factor binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors from rat subject to chronic caloric restriction. Cancer Research, 49, 4135–4141.

    Google Scholar 

  57. Ruggeri, B. A., Klurfeld, D. M., Kritchevsky, D., and Furlanetto, R. W., 1989, Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: Alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Research, 49, 4130–4134.

    Google Scholar 

  58. Sallan, S. E., Hitchcock-bryan, S., Gelber, R., Cassady, J. R., Frei, 111, E., and Nathan, D. G., 1983, Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Research, 43, 5601–5607.

    Google Scholar 

  59. Silverman, J., Powers, J., Stromberg, P., Pultz, J. A., and Kent, S., 1989, Effects on C3H mouse mammary cancer of changing from a high fat to a low fat diet before, at, or after puberty. Cancer Research, 49, 3857–3860.

    Google Scholar 

  60. Stackpole, C. W., Cremona, P., and Kassel, R. L., 1979, Metrizamide gradient purification of mouse tumor cells. Journal of Immunological Methods, 30, 231–243.

    Google Scholar 

  61. Stern, P. H., and Hoffman, R. M., 1986, Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. Journal of the National Cancer Institute, 76, 629–639.

    Google Scholar 

  62. Sundram, K., Khor, H. T., Ong, A. S. H., and Pathmanathan, R., 1989, Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz(a)anthracene. Cancer Research, 49, 1447–1451.

    Google Scholar 

  63. Talmadge, J. E., Benedict, K., Madsen, J., and Fidler, I. J., 1984, Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. Cancer Research, 44, 3801–3805.

    Google Scholar 

  64. Theuer, R. C., 1971, Effect of essential amino acid restriction on the growth of female C57BL mice and their implanted BW 10232 adenocarcinomas. Journal of Nutrition, 101, 223–232.

    Google Scholar 

  65. van Eys, J., 1985, Nutrition and cancer: physiological interrelationships. Annual Review of Nutrition, 5, 435–461.

    Google Scholar 

  66. Vanhamme, L., and Szpirer, C., 1989, Spontaneous and 5-azacytidine-induced revertants of methionine-dependent tumor-derived and H-ras-l-transformed cells. Experimental Cell Research, 181, 159–168.

    Google Scholar 

  67. Xiang, J., and Kimura, A. K., 1986, In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity. Clinical and Experimental Metastasis, 4, 293–309.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and the Pharmacology/Toxicology Program, Washington State University (WSU), 99164-6510, Pullman, WA, U.S.A.

    C. A. Elstad, G. G. Meadows & R. M. Abdallah

Authors
  1. C. A. Elstad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. G. Meadows
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. M. Abdallah
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elstad, C.A., Meadows, G.G. & Abdallah, R.M. Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction. Clin Exp Metast 8, 393–416 (1990). https://doi.org/10.1007/BF00058152

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00058152

Keywords

Search

Navigation